Anterograde venography may improve tarsal imaging in horses: full analysis
A new equine imaging study suggests clinicians may want to rethink how they approach venography of the hock. In The Veterinary Journal, Daniel L. Parra-Torres, Gabriel B. Melo-Neto, and Hector O. Garcia report that an anterograde, distal-access technique provided better vessel visualization and vascular filling in the equine tarsal region than the more familiar retrograde, proximal-access approach. Based on their findings in seven horses, the authors conclude that distal venous access to the vena digitalis dorsalis communis II is the preferred route for venography, and may also be the better choice for intravenous regional limb perfusion in this part of the limb. (vetmed.okstate.edu)
That finding lands in an area of equine practice where technique matters, but standardization is still evolving. Intravenous regional limb perfusion is a well-established tool for managing distal limb infections in horses, especially when clinicians need to achieve high local antimicrobial concentrations while limiting systemic exposure. Reviews and continuing education materials note that variables such as vein selection, tourniquet placement, perfusate volume, and horse positioning can all affect how well a perfusion works. A 2022 meta-analysis went further, concluding that although regional limb perfusion is widely used, the optimal technique remains unclear. (journals.plos.org)
In everyday practice, proximal access sites such as the saphenous vein have commonly been recommended for hindlimb lesions involving the proximal metatarsus, tarsus, or hock region. Trade guidance for practitioners similarly describes the medial saphenous vein as a standard injection site for wounds in the tarsal region. Against that backdrop, the new study is notable because it directly compares proximal, retrograde access with a distal, anterograde route in the same anatomical region, and finds the distal route gives a more complete venographic picture. (dvm360.com)
The practical implication is straightforward: if an anterograde approach fills more of the local venous network, it may offer a better diagnostic study and, by inference, a more efficient route for delivering drugs during regional perfusion. That inference fits with the broader rationale behind limb perfusion, which depends on local vascular delivery under tourniquet isolation to drive drug into affected tissues. It also aligns with prior radiographic work showing that technical choices can change how uniformly contrast or perfusate reaches distal structures. Still, this new study appears small, and the available abstract does not establish clinical outcome benefits, only superior visualization and filling. (sciencedirect.com)
No independent expert commentary specific to this paper was readily available in open sources at the time of reporting. But the surrounding literature helps explain why the findings will get attention. Regional limb perfusion is already considered a core adjunctive treatment for equine distal limb sepsis, and practitioners have long worked around imperfect evidence on the best combination of access site, volume, and tourniquet strategy. A study that identifies a more effective venous entry point for the tarsal region could influence both imaging workflows and treatment protocols, especially in referral and sports medicine settings where hock injuries and synovial infections carry high performance stakes. (journals.plos.org)
Why it matters: For veterinary professionals, this is less about a new technology than a potentially better way to use an established one. If the anterograde approach proves reproducible in clinical cases, it could improve confidence in tarsal venography, help clinicians better define vascular compromise around the hock, and refine how they perform intravenous regional limb perfusion in horses with septic or orthopedic disease. Because limb perfusion success depends on getting adequate local distribution, even a modest technical improvement in vessel filling could matter in cases where time, tissue viability, and antimicrobial stewardship are all in play. (journals.plos.org)
What to watch: The next step is validation in larger clinical populations, ideally with outcome data on drug distribution, ease of use, complications, and treatment response in horses with actual tarsal pathology rather than experimental imaging alone. (journals.plos.org)